保德國際發展(00372.HK)延長千洋投資發行的優先股贖回日期
格隆匯11月9日丨保德國際發展(00372.HK)公告,於2018年4月16日交易時段後,公司附屬PT OBOR Financial Holdings Limited作為認購人與千洋投資有限公司作為發行人及朱濱作為擔保人訂立認購協議,據此,認購人已同意認購,而發行人已同意配發及發行優先股,總認購價為2億港元。
於2020年11月9日,PTOBOR(公司全資附屬公司)與發行人及擔保人訂立補充協議,據此,訂約方有條件同意延長優先股的贖回日期至新贖回日期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.